Go to content
UR Home

Efficacy of interferon alpha 2a in 18 versus 60 months of treatment in patients with primary melanoma of ≥ 1.5 mm tumor thickness: A randomized phase III DeCOG trial

Hauschild, A. ; Volkenandt, M. ; Tilgen, W. ; Linse, R. ; Böttjer, J. ; Vogt, T. ; Spieth, K. ; Eigentler, T. ; Brockmeyer, N. H. ; Weichenthal, M.



Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons